250 related articles for article (PubMed ID: 20702419)
1. Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells.
Xie Z; Tan G; Ding M; Dong D; Chen T; Meng X; Huang X; Tan Y
Nucleic Acids Res; 2010 Dec; 38(22):8027-38. PubMed ID: 20702419
[TBL] [Abstract][Full Text] [Related]
2. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
3. Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.
Chen T; He S; Zhang Z; Gao W; Yu L; Tan Y
Exp Cell Res; 2014 Aug; 326(2):326-35. PubMed ID: 24803390
[TBL] [Abstract][Full Text] [Related]
4. Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction.
Marikawa Y; Tamashiro DA; Fujita TC; Alarcon VB
Stem Cells Dev; 2011 Apr; 20(4):621-33. PubMed ID: 21083502
[TBL] [Abstract][Full Text] [Related]
5. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
[TBL] [Abstract][Full Text] [Related]
6. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
7. Nspc1 regulates the key pluripotent Oct4-Nanog-Sox2 axis in P19 embryonal carcinoma cells via directly activating Oct4.
Li H; Fan R; Sun M; Jiang T; Gong Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):527-32. PubMed ID: 24113379
[TBL] [Abstract][Full Text] [Related]
8. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation.
Tan Y; Xie Z; Ding M; Wang Z; Yu Q; Meng L; Zhu H; Huang X; Yu L; Meng X; Chen Y
Stem Cells Dev; 2010 Sep; 19(9):1365-74. PubMed ID: 19916800
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells.
Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH
Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534
[TBL] [Abstract][Full Text] [Related]
11. The Forkhead box transcription factor FOXM1 is required for the maintenance of cell proliferation and protection against oxidative stress in human embryonic stem cells.
Kwok CT; Leung MH; Qin J; Qin Y; Wang J; Lee YL; Yao KM
Stem Cell Res; 2016 May; 16(3):651-61. PubMed ID: 27062359
[TBL] [Abstract][Full Text] [Related]
12. Oct4 regulates the miR-302 cluster in P19 mouse embryonic carcinoma cells.
Liu H; Deng S; Zhao Z; Zhang H; Xiao J; Song W; Gao F; Guan Y
Mol Biol Rep; 2011 Mar; 38(3):2155-60. PubMed ID: 20857206
[TBL] [Abstract][Full Text] [Related]
13. Foxm1 mediates LIF/Stat3-dependent self-renewal in mouse embryonic stem cells and is essential for the generation of induced pluripotent stem cells.
Tan G; Cheng L; Chen T; Yu L; Tan Y
PLoS One; 2014; 9(4):e92304. PubMed ID: 24743237
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
15. FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors.
Wang Z; Park HJ; Carr JR; Chen YJ; Zheng Y; Li J; Tyner AL; Costa RH; Bagchi S; Raychaudhuri P
Cancer Res; 2011 Jun; 71(12):4292-302. PubMed ID: 21507930
[TBL] [Abstract][Full Text] [Related]
16. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
[TBL] [Abstract][Full Text] [Related]
17. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
18. Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.
Chang G; Miao YL; Zhang Y; Liu S; Kou Z; Ding J; Chen DY; Sun QY; Gao S
PLoS One; 2010 Apr; 5(4):e10320. PubMed ID: 20436676
[TBL] [Abstract][Full Text] [Related]
19. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
Shi G; Gao F; Jin Y
J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
